Kassie Hall, PA
Physician Assistant · Clifton Forge, VANPI 1023605474
Payments from drug & device makers
Across 147 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$760
- AstraZeneca$358
- Lilly USA, LLC$249
- Novo Nordisk$236
- Otsuka America Pharmaceutical, Inc.$183
- Astellas Pharma US Inc$140
- plus $884 from 20 others
What the payments were for
- Food & beverage$2,72097%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $760 |
| AstraZeneca | 17 | $358 |
| Lilly USA, LLC | 14 | $249 |
| Novo Nordisk | 13 | $236 |
| Otsuka America Pharmaceutical, Inc. | 12 | $183 |
| Astellas Pharma US Inc | 4 | $140 |
| Exact Sciences | 6 | $119 |
| Biohaven Pharmaceuticals, Inc. | 2 | $112 |
| Amgen | 6 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Evofem Biosciences, Inc. | 3 | $52 |
| GSK | 3 | $51 |
| Pfizer | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Ascendis Pharma Endocrinology Inc | 2 | $33 |
| Phadia US Inc. | 1 | $26 |
| Novartis | 1 | $26 |
| Exeltis, USA Inc. | 1 | $25 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Kaleo, Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Avion Pharmaceuticals | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$105
How this compares
$2,810 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 66 | $86,444 |
| EliquisApixaban | 54 | $75,900 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $50,075 |
| JanuviaSitagliptin Phosphate | 34 | $49,394 |
| FarxigaDapagliflozin Propanediol | 36 | $44,396 |
| JardianceEmpagliflozin | 29 | $39,301 |
| MounjaroTirzepatide | 21 | $22,276 |
| TrulicityDulaglutide | 14 | $18,835 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $18,717 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $17,368 |
| UbrelvyUbrogepant | 14 | $15,884 |
| WegovySemaglutide | 11 | $14,821 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $9,743 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $7,680 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $6,657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $236 | $101,26577 claims |
| PfizerEliquis | $42 | $75,90054 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $358 | $68,09080 claims |
| GSKTrelegy Ellipta | $51 | $50,07566 claims |
| Lilly USA, LLCMounjaro, Trulicity | $249 | $41,11135 claims |
| AbbVieUbrelvy | $760 | $15,88414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Clifton Forge
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
- Juliette BeristainVirginia Beach$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.